Connective Tissue Growth Factor Activates Pluripotency Genes and Mesenchymal–Epithelial Transition in Head and Neck Cancer Cells
The epithelial–mesenchymal transition (EMT) is a key mechanism in both embryonic development and cancer metastasis. The EMT introduces stem-like properties to cancer cells. However, during somatic cell reprogramming, mesenchymal–epithelial transition (MET), the reverse process of EMT, is a crucial s...
Saved in:
Published in | Cancer research (Chicago, Ill.) Vol. 73; no. 13; pp. 4147 - 4157 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Philadelphia, PA
American Association for Cancer Research
01.07.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The epithelial–mesenchymal transition (EMT) is a key mechanism in both embryonic development and cancer metastasis. The EMT introduces stem-like properties to cancer cells. However, during somatic cell reprogramming, mesenchymal–epithelial transition (MET), the reverse process of EMT, is a crucial step toward pluripotency. Connective tissue growth factor (CTGF) is a multifunctional secreted protein that acts as either an oncoprotein or a tumor suppressor among different cancers. Here, we show that in head and neck squamous cell carcinoma (HNSCC), CTGF promotes the MET and reduces invasiveness. Moreover, we found that CTGF enhances the stem-like properties of HNSCC cells and increases the expression of multiple pluripotency genes. Mechanistic studies showed that CTGF induces c-Jun expression through αvβ3 integrin and that c-Jun directly activates the transcription of the pluripotency genes NANOG, SOX2, and POU5F1. Knockdown of CTGF in TW2.6 cells was shown to reduce tumor formation and attenuate E-cadherin expression in xenotransplanted tumors. In HNSCC patient samples, CTGF expression was positively correlated with the levels of CDH1, NANOG, SOX2, and POU5F1. Coexpression of CTGF and the pluripotency genes was found to be associated with a worse prognosis. These findings are valuable in elucidating the interplay between epithelial plasticity and stem-like properties during cancer progression and provide useful information for developing a novel classification system and therapeutic strategies for HNSCC. Cancer Res; 73(13); 4147–57. ©2013 AACR. |
---|---|
AbstractList | The epithelial-mesenchymal transition (EMT) is a key mechanism in both embryonic development and cancer metastasis. The EMT introduces stem-like properties to cancer cells. However, during somatic cell reprogramming, mesenchymal-epithelial transition (MET), the reverse process of EMT, is a crucial step toward pluripotency. Connective tissue growth factor (CTGF) is a multifunctional secreted protein that acts as either an oncoprotein or a tumor suppressor among different cancers. Here, we show that in head and neck squamous cell carcinoma (HNSCC), CTGF promotes the MET and reduces invasiveness. Moreover, we found that CTGF enhances the stem-like properties of HNSCC cells and increases the expression of multiple pluripotency genes. Mechanistic studies showed that CTGF induces c-Jun expression through αvβ3 integrin and that c-Jun directly activates the transcription of the pluripotency genes NANOG, SOX2, and POU5F1. Knockdown of CTGF in TW2.6 cells was shown to reduce tumor formation and attenuate E-cadherin expression in xenotransplanted tumors. In HNSCC patient samples, CTGF expression was positively correlated with the levels of CDH1, NANOG, SOX2, and POU5F1. Coexpression of CTGF and the pluripotency genes was found to be associated with a worse prognosis. These findings are valuable in elucidating the interplay between epithelial plasticity and stem-like properties during cancer progression and provide useful information for developing a novel classification system and therapeutic strategies for HNSCC.The epithelial-mesenchymal transition (EMT) is a key mechanism in both embryonic development and cancer metastasis. The EMT introduces stem-like properties to cancer cells. However, during somatic cell reprogramming, mesenchymal-epithelial transition (MET), the reverse process of EMT, is a crucial step toward pluripotency. Connective tissue growth factor (CTGF) is a multifunctional secreted protein that acts as either an oncoprotein or a tumor suppressor among different cancers. Here, we show that in head and neck squamous cell carcinoma (HNSCC), CTGF promotes the MET and reduces invasiveness. Moreover, we found that CTGF enhances the stem-like properties of HNSCC cells and increases the expression of multiple pluripotency genes. Mechanistic studies showed that CTGF induces c-Jun expression through αvβ3 integrin and that c-Jun directly activates the transcription of the pluripotency genes NANOG, SOX2, and POU5F1. Knockdown of CTGF in TW2.6 cells was shown to reduce tumor formation and attenuate E-cadherin expression in xenotransplanted tumors. In HNSCC patient samples, CTGF expression was positively correlated with the levels of CDH1, NANOG, SOX2, and POU5F1. Coexpression of CTGF and the pluripotency genes was found to be associated with a worse prognosis. These findings are valuable in elucidating the interplay between epithelial plasticity and stem-like properties during cancer progression and provide useful information for developing a novel classification system and therapeutic strategies for HNSCC. The epithelial–mesenchymal transition (EMT) is a key mechanism in both embryonic development and cancer metastasis. The EMT introduces stem-like properties to cancer cells. However, during somatic cell reprogramming, mesenchymal–epithelial transition (MET), the reverse process of EMT, is a crucial step toward pluripotency. Connective tissue growth factor (CTGF) is a multifunctional secreted protein that acts as either an oncoprotein or a tumor suppressor among different cancers. Here, we show that in head and neck squamous cell carcinoma (HNSCC), CTGF promotes the MET and reduces invasiveness. Moreover, we found that CTGF enhances the stem-like properties of HNSCC cells and increases the expression of multiple pluripotency genes. Mechanistic studies showed that CTGF induces c-Jun expression through αvβ3 integrin and that c-Jun directly activates the transcription of the pluripotency genes NANOG, SOX2, and POU5F1. Knockdown of CTGF in TW2.6 cells was shown to reduce tumor formation and attenuate E-cadherin expression in xenotransplanted tumors. In HNSCC patient samples, CTGF expression was positively correlated with the levels of CDH1, NANOG, SOX2, and POU5F1. Coexpression of CTGF and the pluripotency genes was found to be associated with a worse prognosis. These findings are valuable in elucidating the interplay between epithelial plasticity and stem-like properties during cancer progression and provide useful information for developing a novel classification system and therapeutic strategies for HNSCC. Cancer Res; 73(13); 4147–57. ©2013 AACR. The epithelial-mesenchymal transition (EMT) is a key mechanism in both embryonic development and cancer metastasis. The EMT introduces stem-like properties to cancer cells. However, during somatic cell reprogramming, mesenchymal-epithelial transition (MET), the reverse process of EMT, is a crucial step toward pluripotency. Connective tissue growth factor (CTGF) is a multifunctional secreted protein that acts as either an oncoprotein or a tumor suppressor among different cancers. Here, we show that in head and neck squamous cell carcinoma (HNSCC), CTGF promotes the MET and reduces invasiveness. Moreover, we found that CTGF enhances the stem-like properties of HNSCC cells and increases the expression of multiple pluripotency genes. Mechanistic studies showed that CTGF induces c-Jun expression through αvβ3 integrin and that c-Jun directly activates the transcription of the pluripotency genes NANOG, SOX2, and POU5F1. Knockdown of CTGF in TW2.6 cells was shown to reduce tumor formation and attenuate E-cadherin expression in xenotransplanted tumors. In HNSCC patient samples, CTGF expression was positively correlated with the levels of CDH1, NANOG, SOX2, and POU5F1. Coexpression of CTGF and the pluripotency genes was found to be associated with a worse prognosis. These findings are valuable in elucidating the interplay between epithelial plasticity and stem-like properties during cancer progression and provide useful information for developing a novel classification system and therapeutic strategies for HNSCC. |
Author | Kuo, Min-Liang Chou, Chun-Hung Kuo, Mark Yen-Ping Tai, Shyh-Kuan Wang, Chen-Chien Lin, Been-Ren Chang, Cheng-Chi Hsu, Wen-Hao Chen, Szu-Ta Yang, Muh-Hwa |
Author_xml | – sequence: 1 givenname: Cheng-Chi surname: Chang fullname: Chang, Cheng-Chi – sequence: 2 givenname: Wen-Hao surname: Hsu fullname: Hsu, Wen-Hao – sequence: 3 givenname: Chen-Chien surname: Wang fullname: Wang, Chen-Chien – sequence: 4 givenname: Chun-Hung surname: Chou fullname: Chou, Chun-Hung – sequence: 5 givenname: Mark Yen-Ping surname: Kuo fullname: Kuo, Mark Yen-Ping – sequence: 6 givenname: Been-Ren surname: Lin fullname: Lin, Been-Ren – sequence: 7 givenname: Szu-Ta surname: Chen fullname: Chen, Szu-Ta – sequence: 8 givenname: Shyh-Kuan surname: Tai fullname: Tai, Shyh-Kuan – sequence: 9 givenname: Min-Liang surname: Kuo fullname: Kuo, Min-Liang – sequence: 10 givenname: Muh-Hwa surname: Yang fullname: Yang, Muh-Hwa |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27502034$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/23687336$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kcFu1DAQhi1URLeFRwD5gsQlxY7tOCtOq6jdIrWFw3K2Zp2J1pB1Ftsp2hviFXhDngSn3VKJQ0-Wx99vj-c7IUd-8EjIa87OOFf1e8ZYXSipy7NmcVPwspCsVs_IjCtRF1pKdURm_5hjchLj17xVnKkX5LgUVa2FqGbkVzN4jza5W6QrF-OIdBmGH2lDL8CmIdDFdAYJI_3cj8HthoTe7ukSfS6Bb-k1xlzZ7LfQ__n5-3zn0gZ7Bz1dBfDRJTd46jy9RGjv-Bu032gD3mKgDfZ9fEmed9BHfHVYT8mXi_NVc1lcfVp-bBZXhZVMpQKwA91qxWS51hK4qizobm67ugbWzkF2pbSacSxBW0CmATqrO0AU1op1JU7Ju_t7d2H4PmJMZuuizR2Ax2GMhsuy1lpUc5HRNwd0XG-xNbvgthD25mFuGXh7ACBa6Lv8VeviI5fbLJmQmftwz9kwxBiwM9YlmGaSArjecGYmm2YyZSZTJts0vDSTzZxW_6UfHng69xdCUqXm |
CODEN | CNREA8 |
CitedBy_id | crossref_primary_10_1093_carcin_bgv039 crossref_primary_10_18632_oncotarget_5328 crossref_primary_10_1002_ijc_28972 crossref_primary_10_1016_j_cell_2016_06_028 crossref_primary_10_3892_ijo_2016_3582 crossref_primary_10_1186_s13059_025_03519_4 crossref_primary_10_1002_ijc_28690 crossref_primary_10_1158_1078_0432_CCR_22_0761 crossref_primary_10_1016_j_ebiom_2020_102717 crossref_primary_10_3390_cancers12051088 crossref_primary_10_1016_j_neo_2015_01_004 crossref_primary_10_1016_j_oraloncology_2015_04_004 crossref_primary_10_1038_ncb3611 crossref_primary_10_1158_0008_5472_CAN_17_1172 crossref_primary_10_18632_oncotarget_1998 crossref_primary_10_1055_s_0038_1673588 crossref_primary_10_1177_0022034515601960 crossref_primary_10_3389_fonc_2018_00505 crossref_primary_10_3390_ijms23147689 crossref_primary_10_1186_1756_8722_7_19 crossref_primary_10_1186_s13005_016_0106_0 crossref_primary_10_1002_1878_0261_12096 crossref_primary_10_3390_biomedicines10081946 crossref_primary_10_1016_j_phymed_2018_04_016 crossref_primary_10_3390_ijms22083888 crossref_primary_10_1186_s12943_019_0983_5 crossref_primary_10_1016_j_jfma_2017_04_003 crossref_primary_10_1007_s12094_017_1751_x crossref_primary_10_18632_oncotarget_4000 crossref_primary_10_1038_bjc_2014_153 crossref_primary_10_1146_annurev_pathol_020117_044127 crossref_primary_10_1186_s13046_023_02671_8 crossref_primary_10_3389_fonc_2018_00431 crossref_primary_10_1038_cddis_2017_248 crossref_primary_10_1101_sqb_2016_81_030957 crossref_primary_10_1186_s41232_017_0041_x crossref_primary_10_15407_fz61_01_010 crossref_primary_10_18632_oncotarget_9549 crossref_primary_10_1016_j_jtbi_2021_110677 crossref_primary_10_1111_cas_13202 crossref_primary_10_1016_j_yexcr_2013_12_024 crossref_primary_10_18632_oncotarget_9342 crossref_primary_10_18632_oncotarget_2073 crossref_primary_10_1186_s12964_024_01957_4 crossref_primary_10_1002_cbin_10398 crossref_primary_10_1016_j_job_2024_02_005 crossref_primary_10_4014_jmb_2110_10032 crossref_primary_10_3390_cells8091017 crossref_primary_10_3390_ijms19113620 crossref_primary_10_1007_s13577_014_0092_0 crossref_primary_10_1071_RD16033 crossref_primary_10_1089_cbr_2020_3988 crossref_primary_10_1186_s12967_023_04343_9 crossref_primary_10_1016_j_molonc_2015_05_006 crossref_primary_10_1016_j_pharmthera_2016_09_002 crossref_primary_10_15430_JCP_2018_23_1_1 crossref_primary_10_3390_ijms20040891 crossref_primary_10_3892_ol_2015_3487 crossref_primary_10_1126_science_1234850 crossref_primary_10_1097_CM9_0000000000000683 crossref_primary_10_1007_s10555_021_10003_5 crossref_primary_10_1186_1475_2867_14_61 crossref_primary_10_18632_oncotarget_13957 crossref_primary_10_1007_s00432_015_2020_4 crossref_primary_10_1002_stem_2447 crossref_primary_10_3390_ijms22126626 crossref_primary_10_1016_j_trsl_2014_05_007 crossref_primary_10_1093_carcin_bgv034 crossref_primary_10_1084_jem_20140692 |
Cites_doi | 10.1126/science.1151526 10.1371/journal.pone.0021911 10.1371/journal.pone.0041335 10.1371/journal.pone.0002888 10.1038/ncb1998 10.1242/jcs.03460 10.1016/j.cellsig.2009.12.008 10.1016/j.cell.2006.07.024 10.1016/j.stem.2010.04.014 10.1016/j.stem.2010.04.015 10.4081/gh.2010.203 10.1023/A:1008845219266 10.1053/j.gastro.2004.10.007 10.1038/nrc3184 10.1172/JCI59218 10.1158/0008-5472.CAN-10-2638 10.1016/j.cell.2009.11.007 10.1179/016164102101200573 10.1038/nm.2401 10.1016/j.bbrc.2011.07.025 10.1242/dev.024398 10.1007/s11373-008-9264-9 10.1038/embor.2011.88 10.1172/JCI39104 10.1093/jnci/djh059 10.1073/pnas.0610117104 10.1001/archotol.132.7.762 10.1038/onc.2011.423 10.1371/journal.pone.0012445 10.1038/nature06534 10.1038/ncb2099 10.1200/JCO.2008.17.0266 10.1007/s00109-007-0287-x 10.1038/cr.2010.127 10.1016/j.oraloncology.2006.07.007 10.1016/j.cell.2008.03.027 10.1016/0278-2391(90)90436-6 |
ContentType | Journal Article |
Copyright | 2014 INIST-CNRS 2013 AACR. |
Copyright_xml | – notice: 2014 INIST-CNRS – notice: 2013 AACR. |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1158/0008-5472.CAN-12-4085 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1538-7445 |
EndPage | 4157 |
ExternalDocumentID | 23687336 27502034 10_1158_0008_5472_CAN_12_4085 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -ET 18M 29B 2WC 34G 39C 53G 5GY 5RE 5VS 6J9 AAFWJ AAJMC AAYXX ABOCM ACGFO ACIWK ACPRK ACSVP ADBBV ADCOW ADNWM AENEX AETEA AFHIN AFOSN AFRAH AFUMD ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CITATION CS3 DIK DU5 EBS EJD F5P FRP GX1 H13 IH2 KQ8 L7B LSO OK1 P0W P2P PQQKQ RCR RHI RNS SJN TR2 UDS W2D W8F WH7 WOQ YKV YZZ .55 .GJ 3O- 8WZ A6W AFFNX AI. C1A D0S IQODW J5H MVM OHT VH1 WHG X7M XJT ZCG ZGI CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c405t-aefa7d75042b74a156ca7f9cf88a0d9a4f24c701e2a7cae07aafc7faee3cc3b63 |
ISSN | 0008-5472 1538-7445 |
IngestDate | Thu Jul 10 23:17:38 EDT 2025 Mon Jul 21 06:04:59 EDT 2025 Mon Jul 21 09:16:07 EDT 2025 Tue Jul 01 04:18:02 EDT 2025 Thu Apr 24 23:02:57 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 13 |
Keywords | Gene ENT disease Head and neck cancer Connective tissue growth factor Genetics Malignant tumor Epithelial mesenchymal transition Cell transformation Cell In vitro Pluripotency Cancer |
Language | English |
License | CC BY 4.0 2013 AACR. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c405t-aefa7d75042b74a156ca7f9cf88a0d9a4f24c701e2a7cae07aafc7faee3cc3b63 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 23687336 |
PQID | 1428773693 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_1428773693 pubmed_primary_23687336 pascalfrancis_primary_27502034 crossref_citationtrail_10_1158_0008_5472_CAN_12_4085 crossref_primary_10_1158_0008_5472_CAN_12_4085 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2013-07-01 |
PublicationDateYYYYMMDD | 2013-07-01 |
PublicationDate_xml | – month: 07 year: 2013 text: 2013-07-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Philadelphia, PA |
PublicationPlace_xml | – name: Philadelphia, PA – name: United States |
PublicationTitle | Cancer research (Chicago, Ill.) |
PublicationTitleAlternate | Cancer Res |
PublicationYear | 2013 |
Publisher | American Association for Cancer Research |
Publisher_xml | – name: American Association for Cancer Research |
References | Mani (2022061704045961300_bib3) 2008; 133 Wellner (2022061704045961300_bib6) 2009; 11 Yu (2022061704045961300_bib9) 2007; 318 Thiery (2022061704045961300_bib2) 2009; 139 Yang (2022061704045961300_bib7) 2010; 12 Nakerakanti (2022061704045961300_bib33) 2011; 6 Li (2022061704045961300_bib11) 2010; 7 Samavarchi-Tehrani (2022061704045961300_bib12) 2010; 7 Chambers (2022061704045961300_bib29) 2009; 136 Chen (2022061704045961300_bib18) 2007; 120 Kalluri (2022061704045961300_bib1) 2009; 119 Ocaña (2022061704045961300_bib14) 2010; 20 Kok (2022061704045961300_bib24) 2007; 43 Morel (2022061704045961300_bib4) 2008; 3 Yang (2022061704045961300_bib22) 2012; 31 Glinsky (2022061704045961300_bib28) 2008; 26 Hu (2022061704045961300_bib40) 2011; 411 Lin (2022061704045961300_bib20) 2005; 128 Wong (2022061704045961300_bib23) 1990; 48 Chiou (2022061704045961300_bib38) 2010; 70 Chiang (2022061704045961300_bib32) 2010; 4 Nguyen (2022061704045961300_bib5) 2012; 12 Prince (2022061704045961300_bib27) 2007; 104 Greene (2022061704045961300_bib34) 2002 Pan (2022061704045961300_bib17) 2002; 24 2022061704045961300_bib25 Han (2022061704045961300_bib39) 2012; 7 2022061704045961300_bib26 Luft (2022061704045961300_bib15) 2008; 86 Chang (2022061704045961300_bib19) 2004; 96 Kong (2022061704045961300_bib37) 2010; 5 Garavello (2022061704045961300_bib21) 2006; 132 Celià-Terrassa (2022061704045961300_bib35) 2012; 122 Korpal (2022061704045961300_bib36) 2011; 17 Redmer (2022061704045961300_bib13) 2011; 12 Chu (2022061704045961300_bib16) 2008; 15 Takahashi (2022061704045961300_bib8) 2006; 126 Park (2022061704045961300_bib10) 2008; 451 Mork (2022061704045961300_bib31) 1998; 9 Shaulian (2022061704045961300_bib30) 2010; 22 28572507 - Cancer Res. 2017 Jun 1;77(11):3127 |
References_xml | – volume: 318 start-page: 1917 year: 2007 ident: 2022061704045961300_bib9 article-title: Induced pluripotent stem cell lines derived from human somatic cells publication-title: Science doi: 10.1126/science.1151526 – volume: 6 start-page: e21911 year: 2011 ident: 2022061704045961300_bib33 article-title: CCN2 is required for the TGF-β induced activation of Smad1-Erk1/2 signaling network publication-title: PLoS ONE doi: 10.1371/journal.pone.0021911 – volume: 7 start-page: e41335 year: 2012 ident: 2022061704045961300_bib39 article-title: Silencing SOX2 induced mesenchymal–epithelial transition and its expression predicts liver and lymph node metastasis of CRC patients publication-title: PLoS ONE doi: 10.1371/journal.pone.0041335 – volume: 3 start-page: e2888 year: 2008 ident: 2022061704045961300_bib4 article-title: Generation of breast cancer stem cells through epithelial–mesenchymal transition publication-title: PLoS ONE doi: 10.1371/journal.pone.0002888 – volume: 11 start-page: 1487 year: 2009 ident: 2022061704045961300_bib6 article-title: The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs publication-title: Nat Cell Biol doi: 10.1038/ncb1998 – volume: 120 start-page: 2053 year: 2007 ident: 2022061704045961300_bib18 article-title: CTGF enhances the motility of breast cancer cells via an integrin-αvβ3–ERK1/2-dependent S100A4-upregulated pathway publication-title: J Cell Sci doi: 10.1242/jcs.03460 – volume: 22 start-page: 894 year: 2010 ident: 2022061704045961300_bib30 article-title: AP-1-the jun proteins: oncogenes or tumor suppressors in disguise? publication-title: Cell Signal doi: 10.1016/j.cellsig.2009.12.008 – volume: 126 start-page: 663 year: 2006 ident: 2022061704045961300_bib8 article-title: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors publication-title: Cell doi: 10.1016/j.cell.2006.07.024 – volume: 7 start-page: 51 year: 2010 ident: 2022061704045961300_bib11 article-title: A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts publication-title: Cell Stem Cell doi: 10.1016/j.stem.2010.04.014 – volume: 7 start-page: 64 year: 2010 ident: 2022061704045961300_bib12 article-title: Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming publication-title: Cell Stem Cell doi: 10.1016/j.stem.2010.04.015 – volume: 4 start-page: 230 year: 2010 ident: 2022061704045961300_bib32 article-title: Elucidating the underlying causes of oral cancer through spatial clustering in high-risk areas of Taiwan with a distinct gender ratio of incidence publication-title: Geospat Health doi: 10.4081/gh.2010.203 – volume: 9 start-page: 37 year: 1998 ident: 2022061704045961300_bib31 article-title: Squamous cell carcinomas of the head and neck in Norway, 1953–92: an epidemiologic study of a low-risk population publication-title: Cancer Causes Control doi: 10.1023/A:1008845219266 – volume: 128 start-page: 9 year: 2005 ident: 2022061704045961300_bib20 article-title: Connective tissue growth factor inhibits metastasis and acts as an independent prognostic marker in colorectal cancer publication-title: Gastroenterology doi: 10.1053/j.gastro.2004.10.007 – ident: 2022061704045961300_bib26 – volume: 12 start-page: 133 year: 2012 ident: 2022061704045961300_bib5 article-title: Cancer stem cells: an evolving concept publication-title: Nat Rev Cancer doi: 10.1038/nrc3184 – volume: 122 start-page: 1849 year: 2012 ident: 2022061704045961300_bib35 article-title: Epithelial–mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells publication-title: J Clin Invest doi: 10.1172/JCI59218 – volume: 70 start-page: 10433 year: 2010 ident: 2022061704045961300_bib38 article-title: Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial–mesenchymal transdifferentiation publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-10-2638 – start-page: 17 year: 2002 ident: 2022061704045961300_bib34 article-title: Head and neck – volume: 139 start-page: 871 year: 2009 ident: 2022061704045961300_bib2 article-title: Epithelial–mesenchymal transitions in development and disease publication-title: Cell doi: 10.1016/j.cell.2009.11.007 – volume: 24 start-page: 677 year: 2002 ident: 2022061704045961300_bib17 article-title: Neoplastic cells and proliferating endothelial cells express connective tissue growth factor (CTGF) in glioblastoma publication-title: Neurol Res doi: 10.1179/016164102101200573 – volume: 17 start-page: 1101 year: 2011 ident: 2022061704045961300_bib36 article-title: Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization publication-title: Nat Med doi: 10.1038/nm.2401 – volume: 411 start-page: 786 year: 2011 ident: 2022061704045961300_bib40 article-title: Downregulation of transcription factor Oct4 induces an epithelial-to-mesenchymal transition via enhancement of Ca2+ influx in breast cancer cells publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2011.07.025 – volume: 136 start-page: 2311 year: 2009 ident: 2022061704045961300_bib29 article-title: The transcriptional foundation of pluripotency publication-title: Development doi: 10.1242/dev.024398 – volume: 15 start-page: 675 year: 2008 ident: 2022061704045961300_bib16 article-title: Connective tissue growth factor (CTGF) and cancer progression publication-title: J Biomed Sci doi: 10.1007/s11373-008-9264-9 – volume: 12 start-page: 720 year: 2011 ident: 2022061704045961300_bib13 article-title: E-cadherin is crucial for embryonic stem cell pluripotency and can replace OCT4 during somatic cell reprogramming publication-title: EMBO Rep doi: 10.1038/embor.2011.88 – volume: 119 start-page: 1420 year: 2009 ident: 2022061704045961300_bib1 article-title: The basics of epithelial–mesenchymal transition publication-title: J Clin Invest doi: 10.1172/JCI39104 – volume: 96 start-page: 364 year: 2004 ident: 2022061704045961300_bib19 article-title: Connective tissue growth factor and its role in lung adenocarcinoma invasion and metastasis publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djh059 – volume: 104 start-page: 973 year: 2007 ident: 2022061704045961300_bib27 article-title: Identification of a subpopulation of cells with cancer stem cell. Properties in head and neck squamous cell carcinoma publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0610117104 – volume: 132 start-page: 762 year: 2006 ident: 2022061704045961300_bib21 article-title: Risk factors for distant metastases in head and neck squamous cell carcinoma publication-title: Arch Otolaryngol Head Neck Surg doi: 10.1001/archotol.132.7.762 – volume: 31 start-page: 2401 year: 2012 ident: 2022061704045961300_bib22 article-title: Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling publication-title: Oncogene doi: 10.1038/onc.2011.423 – volume: 5 start-page: e12445 year: 2010 ident: 2022061704045961300_bib37 article-title: Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells publication-title: PLoS ONE doi: 10.1371/journal.pone.0012445 – volume: 451 start-page: 141 year: 2008 ident: 2022061704045961300_bib10 article-title: Reprogramming of human somatic cells to pluripotency with defined factors publication-title: Nature doi: 10.1038/nature06534 – volume: 12 start-page: 982 year: 2010 ident: 2022061704045961300_bib7 article-title: Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition publication-title: Nat Cell Biol doi: 10.1038/ncb2099 – volume: 26 start-page: 2846 year: 2008 ident: 2022061704045961300_bib28 article-title: Stemness” genomics law governs clinical behavior of human cancer: implications for decision making in disease management publication-title: J Clin Oncol doi: 10.1200/JCO.2008.17.0266 – volume: 86 start-page: 1 year: 2008 ident: 2022061704045961300_bib15 article-title: CCN2, the connective tissue growth factor publication-title: J Mol Med doi: 10.1007/s00109-007-0287-x – ident: 2022061704045961300_bib25 – volume: 20 start-page: 1086 year: 2010 ident: 2022061704045961300_bib14 article-title: Epithelial plasticity, stemness and pluripotency publication-title: Cell Res doi: 10.1038/cr.2010.127 – volume: 43 start-page: 639 year: 2007 ident: 2022061704045961300_bib24 article-title: Establishment and characterization of a tumorigenic cell line from areca quid and tobacco smoke-associated buccal carcinoma publication-title: Oral Oncol doi: 10.1016/j.oraloncology.2006.07.007 – volume: 133 start-page: 704 year: 2008 ident: 2022061704045961300_bib3 article-title: The epithelial–mesenchymal transition generates cells with properties of stem cells publication-title: Cell doi: 10.1016/j.cell.2008.03.027 – volume: 48 start-page: 385 year: 1990 ident: 2022061704045961300_bib23 article-title: Characterization of two new cell lines derived from oral cavity human squamous cell carcinomas—OC1 and OC2 publication-title: J Oral Maxillofac Surg doi: 10.1016/0278-2391(90)90436-6 – reference: 28572507 - Cancer Res. 2017 Jun 1;77(11):3127 |
SSID | ssj0005105 |
Score | 2.3907633 |
Snippet | The epithelial–mesenchymal transition (EMT) is a key mechanism in both embryonic development and cancer metastasis. The EMT introduces stem-like properties to... The epithelial-mesenchymal transition (EMT) is a key mechanism in both embryonic development and cancer metastasis. The EMT introduces stem-like properties to... |
SourceID | proquest pubmed pascalfrancis crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 4147 |
SubjectTerms | Animals Antineoplastic agents Binding Sites Biological and medical sciences Carcinoma, Squamous Cell - metabolism Carcinoma, Squamous Cell - mortality Carcinoma, Squamous Cell - pathology Cell Movement Connective Tissue Growth Factor - physiology Disease-Free Survival Epithelial-Mesenchymal Transition Gene Expression Regulation, Neoplastic Head and Neck Neoplasms - metabolism Head and Neck Neoplasms - mortality Head and Neck Neoplasms - pathology HEK293 Cells Homeodomain Proteins - genetics Homeodomain Proteins - metabolism Humans Kaplan-Meier Estimate Medical sciences Mice Mice, Nude Multiple tumors. Solid tumors. Tumors in childhood (general aspects) Nanog Homeobox Protein Neoplasm Invasiveness Neoplasm Transplantation Neoplastic Stem Cells - metabolism Octamer Transcription Factor-3 - genetics Octamer Transcription Factor-3 - metabolism Oligonucleotide Array Sequence Analysis Otorhinolaryngology (head neck, general aspects and miscellaneous) Otorhinolaryngology. Stomatology Pharmacology. Drug treatments Proto-Oncogene Proteins c-jun - metabolism SOXB1 Transcription Factors - genetics SOXB1 Transcription Factors - metabolism Spheroids, Cellular - metabolism Transcriptional Activation Transcriptome Tumors |
Title | Connective Tissue Growth Factor Activates Pluripotency Genes and Mesenchymal–Epithelial Transition in Head and Neck Cancer Cells |
URI | https://www.ncbi.nlm.nih.gov/pubmed/23687336 https://www.proquest.com/docview/1428773693 |
Volume | 73 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ditQwFA7jCiKI-O_4s0TwbujYadOmvRzKLoOyg8Iu7F1J09RZtnaGnRbRK_EVfDcfwCfxnKRpuzL-rDdlyCRpyflykpx85xxCXqqCZyr0cif2hOvgCcGJPBU7MoOplwtexLkmyC7DxQl7fRqcjkbfB6ylps6m8vNOv5L_kSqUgVzRS_YKku06hQL4DfKFJ0gYnv8kY81S0QoLxhwHEE1JH-vV5FBn0ZnMpU5epraTt2UD2mFda0dLDDVtQjMfoe-RXH36IErLevAPNuimUaIlXS9kZ5YOuQA46FZLJc8nCcLlYpKostwOd7hteRtEaKVviQ3dQ6ujspwOjA-JNVcnK1W9d6BiB7Nto-l_qnIWYt2b_fvqWLv3Y0tW68b800CLpl2PW3MGppbg1pxhVXTkBMzk85mqXitzZuJOWrVtMqBYePoDJcxmJohnu6ADAPnuxSKIDLvSvHCazJdIVMGYb_3qaBkBvyyaHZVRH6KCCC_xoxS7SaGbdOal2M01ct2D4wtm1njzro9iH7TUWvvm1rMMunm182su7ZlubcQWpm9h8q78_mCkN0jHd8jt9mRD5wamd8lIVffIjaOWu3GffO3RSg1aqUErNWilHVrpEK1Uo5UC7ugArT--fOtxSnuc0rOKIk51fcQpNXikGqcPyMnhwXGycNoMII6Eg0TtCFUInmMGAi_jTIAmkag-ZBFFws1jwQqPSe7OlCe4FMrlQhSSF0IpX0o_C_2HZK9aV-oxoUE0c7M8zkAaikmZZ4GbB9LLYx_gwXg4JsyOcSrb8PiYpaVM_yjhMZl2zTYmPszfGuxfEmDXChMteK7PxuSFlWgKqh7v70Sl1s02xeCInPth7I_JIyPqvrUfRhjZ9MlVv-cpudlPw2dkr75o1HPYZ9fZvgbtTzdMzIk |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Connective+Tissue+Growth+Factor+Activates+Pluripotency+Genes+and+Mesenchymal%E2%80%93Epithelial+Transition+in+Head+and+Neck+Cancer+Cells&rft.jtitle=Cancer+research+%28Chicago%2C+Ill.%29&rft.au=Chang%2C+Cheng-Chi&rft.au=Hsu%2C+Wen-Hao&rft.au=Wang%2C+Chen-Chien&rft.au=Chou%2C+Chun-Hung&rft.date=2013-07-01&rft.issn=0008-5472&rft.eissn=1538-7445&rft.volume=73&rft.issue=13&rft.spage=4147&rft.epage=4157&rft_id=info:doi/10.1158%2F0008-5472.CAN-12-4085&rft.externalDBID=n%2Fa&rft.externalDocID=10_1158_0008_5472_CAN_12_4085 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-5472&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-5472&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-5472&client=summon |